Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
PXS-5505 dihydrochloride
AOB16988
CAS: 2409964-23-2 (free base: 2409963-83-1)
Chemical Name: LOX-IN-3; (Z)-3-Fluoro-4-quinolin-8-ylsulfonylbut-2-en-1-amine Dihydrochloride
988 Items
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $12.75 | Total: $63.75 |
| 1 | 10 | $10.80 | Total: $108.00 |
| 1 | 25 | $9.15 | Total: $228.75 |
| 1 | 50 | $7.80 | Total: $390.00 |
| 1 | 100 | $6.75 | Total: $675.00 |
Overview
Novel orally available, small-molecule, irreversible inhibitor of all lysyl oxidases (LOX) family members
Chemical Properties
| Molecular Formula | C13H15Cl2FN2O2S |
| Molecular Weight | 353.2 |
| CAS Numbers | 2409964-23-2 |
| Solubility | DMSO and Water |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | (Z)-3-fluoro-4-quinolin-8-ylsulfonylbut-2-en-1-amine dihydrochloride |
| InChl Key | YYYHSAUHJBNINZ-LEOXJOGCSA-N |
| InChl Code | InChI=1S/C13H13FN2O2S.2ClH/c14-11(6-7-15)9-19(17,18)12-5-1-3-10-4-2-8-16-13(10)12;;/h1-6,8H,7,9,15H2;2*1H/b11-6- |
| SMILES Code | C1=CC2=C(C(=C1)S(=O)(=O)CC(=CCN)F)N=CC=C2.Cl.Cl |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
LOX-IN-3 dihydrochloride; PXS5505
References
1) Yao, Y., et al.,Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis; Int. J. Mol. Sci. 2022, 23(10), 5533; https://doi.org/10.3390/ijms23105533